Overview
‘Growth or value’ has framed many investment narratives. But Monks’ Malcolm MacColl explains the two aren’t at odds.

Related insights

Medpace: easing the bottleneck in drug development
Why Global Alpha sees Medpace as part of drug development’s essential infrastructure.July 2026
Monthly commentary|7 minutes
Global Alpha Q2 update
Investment specialist Ben Drury reflects on recent performance, portfolio changes and market developments.July 2026
Video|6 minutes
Global Alpha Forum: the changing growth opportunity set
How Global Alpha is seeking growth across companies, regions and real-world constraints.July 2026
Article|Long read



